ScienceOpen: research and publishing network

For Researchers

Search
Advanced search

3

views

    

0

recommends

0

shares

Record: found
Abstract: found
Article: found

Is Open Access

Inclusion of omalizumab in a trastuzumab desensitization protocol Translated title: Inclusión de omalizumab en un protocolo de desensibilización de trastuzumab

case-report

Author(s): Ester María Barreiro-Fernández , Manuel David Gil-Sierra , María del Pilar Briceño-Casado , Carmen Martínez-Díaz , Esmeralda Ríos-Sánchez

Publication date (Print and electronic): June 2022

Journal: Farmacia Hospitalaria

Publisher: Grupo Aula Médica

Keywords: Desensitization, Premedication, Antineoplastic agents, Omalizumab, Trastuzumab, Desensibilización, Premedicación, Agentes antineoplásicos, Omalizumab, Trastuzumab

Read this article at

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Most cited references 9

Record: found
Abstract: found
Article: not found

Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence.

Marcus Maurer, Martin Metz, Randolf Brehler … (2018)

Omalizumab, a recombinant anti-IgE antibody, effectively treats chronic spontaneous urticaria. Evidence is lacking in patients with chronic inducible urticarias (CIndUs), which are frequently H1-antihistamine resistant.

0 comments Cited 50 times – based on 0 reviews      Review now

Record: found
Abstract: not found
Article: not found

Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.

Lynda C. Schneider, Lisa Hoyte, Dale T. Umetsu … (2011)

0 comments Cited 44 times – based on 0 reviews      Review now

Record: found
Abstract: not found
Article: not found

Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels.

Samar Ojaimi, Paul R Harnett, David Fulcher (2014)

0 comments Cited 9 times – based on 0 reviews      Review now

Author and article information

Journal

Journal ID (publisher-id): fh

Title: Farmacia Hospitalaria

Abbreviated Title: Farm Hosp.

Publisher: Grupo Aula Médica (Toledo, Toledo, Spain )

ISSN (Print): 1130-6343

ISSN (Electronic): 2171-8695

Publication date (Print and electronic): June 2022

Volume: 46

Issue: 3

Pages: 199-201

Affiliations

[1] Puerto Real Cádiz orgnameHospital Universitario de Puerto Real orgdiv1Pharmacy Department Spain

[2] Sevilla orgnameUniversidad de Sevilla orgdiv1Facultad de Farmacia orgdiv2Department of Pharmacology Spain

[3] Talavera de la Reina Toledo orgnameHospital General Nuestra Señora del Prado orgdiv1Pharmacy Department Spain

Article

Publisher ID: S1130-63432022000300014 Publisher ID: S1130-6343(22)04600300014

DOI: 10.7399/fh.11809

SO-VID: 9f0c653a-5139-4684-a386-8a47db218f48

License:

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

History

Date accepted : 20 December 2021

Date received : 30 July 2021

Page count

Figures: 0, Tables: 0, Equations: 0, References: 10, Pages: 3

Product

SciELO Spain

Categories

Subject: Clinical Cases

Keywords: Trastuzumab,Desensitization,Premedication,Antineoplastic agents,Omalizumab,Desensibilización,Premedicación,Agentes antineoplásicos

Data availability:

Keywords: Trastuzumab, Desensitization, Premedication, Antineoplastic agents, Omalizumab, Desensibilización, Premedicación, Agentes antineoplásicos

Comments

Comment on this article